Lv51
1048 积分 2020-10-26 加入
Rituximab, Acalabrutinib, and Durvalumab for Primary Central Nervous System Lymphoma: A Single-Arm, Phase Ib, Multicenter Study
4天前
已关闭
Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance
6天前
已完结
Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells
6天前
已完结
Circulating tumor DNA from blood and cerebrospinal fluid in DLBCL: simultaneous evaluation of mutations, IG rearrangement, and IG clonality
13天前
已完结
ABCL-614: Circulating Tumor DNA as a Biomarker for Minimal Residual Disease and Early Relapse Detection in Diffuse Large B-Cell Lymphoma: A Systematic Review
13天前
已关闭
Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025
17天前
已完结
The impact of azole antifungal drugs on imatinib metabolism in human liver microsomes
21天前
已完结
Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study
21天前
已完结
Expert Opinion on Managing Adverse Reactions Associated With Acalabrutinib Therapy: A Delphi Consensus From France
23天前
已完结
CLL-745: SEQUOIA 5-Year Follow-up in Arm C: Frontline Zanubrutinib in Patients With del(17p) and Treatment-Naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
25天前
已完结
皖公网安备34019202002308
